Compared to Semaglutide and Tirzepatide, retatrutide's special inclusion of glucagon receptor agonism alongside GIP and GLP-1 receptor agonism offers a distinct pharmacological profile. While Semaglutide is often a GLP-1 receptor agonist and Tirzepatide brings together GLP-one and GIP receptor agonism, retatrutide's triple mechanism could most likely supply broader metabolic https://anatoleu988lbp6.bmswiki.com/user